Big pharma stocks appeal to many investors. Why? They often offer relative stability and solid (albeit not always spectacular) growth prospects. Many of these stocks also provide strong dividends.
We asked three Motley Fool contributors to pick the smartest big pharma stocks to buy in September. Here’s why they chose Merck (NYSE: MRK), Pfizer (NYSE: PFE), and Teva Pharmaceutical (NYSE: TEVA).
Image source: Getty Images.